Journal
American Journal of Human Genetics
Publication Date
10-6-2022
Volume
109
Issue
10
First Page
1727
Last Page
1741
Document Type
Open Access Publication
DOI
10.1016/j.ajhg.2022.08.007
Rights and Permissions
Yin X, Bose D, Kwon A, Hanks SC, Jackson AU, Stringham HM, Welch R, Oravilahti A, Fernandes Silva L; FinnGen; Locke AE, Fuchsberger C, Service SK, Erdos MR, Bonnycastle LL, Kuusisto J, Stitziel NO, Hall IM, Morrison J, Ripatti S, Palotie A, Freimer NB, Collins FS, Mohlke KL, Scott LJ, Fauman EB, Burant C, Boehnke M, Laakso M, Wen X. Integrating transcriptomics, metabolomics, and GWAS helps reveal molecular mechanisms for metabolite levels and disease risk. Am J Hum Genet. 2022 Oct 6;109(10):1727-1741. doi: 10.1016/j.ajhg.2022.08.007. Copyright 2022 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Yin, Xianyong; Locke, Adam E; Stitziel, Nathan O; and et al., "Integrating transcriptomics, metabolomics, and GWAS helps reveal molecular mechanisms for metabolite levels and disease risk." American Journal of Human Genetics. 109, 10. 1727 - 1741. (2022).
https://digitalcommons.wustl.edu/oa_4/1417
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.